Domenico Russo
8PUBLICATIONS
79CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 15, 2025
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial.Mohamad Mohty, Gerard Socié, Jeff Szer
|Jun 25, 2025
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study.Robert Zeiser, Domenico Russo, Ron Ram
|Jul 02, 2024
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas.Federico Stella, Annalisa Chiappella, Beatrice Casadei
|Jan 17, 2023
Refining patients' care in myelofibrosis: looking at second primary malignancies.Nicola Polverelli, Michele Malagola, Domenico Russo
|Feb 17, 2021
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study.Michele Malagola, Alessandra Iurlo, Elisabetta Abruzzese
|Dec 15, 2020
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection.Irene Cassaniti, Anna A Colombo, Paolo Bernasconi
Pageof 2
Frequent Collaborators
4 joint publications
Michele Malagola
3 joint publications
Nicola Polverelli
2 joint publications
Francesca Bonifazi
2 joint publications
Giovanni Grillo
2 joint publications
Robert Zeiser
2 joint publications
Simona Bernardi
1 joint publications
Elena Gabusi
1 joint publications
Jaime Sanz
1 joint publications
Silvia Agnelli
1 joint publications
Camillo Almici
